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Page 1442, right column, first and second paragraphs of Results (FAM-TAMRA Peptide Cleavage by Recombinant TACE and ADAM-10)
We first tested the validity of the FAM-TAMRA TNF peptide in vitro using recombinant enzymes. Peptide cleavage was measured by real-time monitoring of fluorescent signal using a spectrofluorimeter. Hydrolysis of 5 mM FAM-TAMRA TNF peptide by 0.7 nM rTACE produced a fourfold increase above the background fluorescent signal over 60 min ( Figure 1a ). The reaction curve was linear over time with the rate of peptide cleavage effectively constant. No peptide cleavage was observed in the absence of enzyme, and complete inhibition of the cleavage was achieved by 46 mM of GM6001 with an IC50 of 20.6±1.2 (s.e.) nM (n ¼ 4). The assay was highly sensitive, able to detect subnanomolar concentrations of TACE with a k cat /K m of 9.89 ( ± 0.35) Â 10 3 M À1 s À1 being determined (n ¼ 8). The peptide could not be dissolved in the buffer solution at concentrations high enough to allow accurate determination of K m and V max .
ADAM-10, another protease of the ADAM family, has been reported to cleave TNF-based peptides.
6 Hydrolysis of 5 mM FAM-TAMRA TNF peptide by 1.7 nM rADAM-10 over 60 min produced a 2.3-fold increase of the fluorescent signal above the background (Figure 1a) . However, k cat /K m was 1.23 ( ± 0.04) Â 10 3 M À1 s À1 for rADAM-10 (n ¼ 8), that is, more than eightfold lower than for TACE, indicating that ADAM-10 is less efficient at cleaving this peptide.
The corrections to enzyme concentrations described above also apply to Figure 1 , which should correctly read: 
